Enstilar ® foam spray is designed to be sprayed onto your skin. Simply apply where your doctor has indicated, following these simple steps: Close-up images of patients with psoriasis before Close-up images of patients with psoriasis before treatment and 4 weeks after treatment treatment and 4 weeks after treatment HIP FOREARM BASELINE WEEK 4 This leaflet is intended for patients prescribed Enstilar ® (calcipotriol/betamethasone dipropionate) cutaneous foam. This leaflet does not replace the Patient Information Leaflet (PIL) provided with your medicine which you must read carefully. Enstilar ® contains calcipotriol and betamethasone dipropionate (50 micrograms/g + 0.5 mg/g) in a foam spray formulation. • Enstilar ® is a foam spray plaque psoriasis treatment for adult patients that comes in a can • Spray onto the affected area, as directed by your prescriber, once-daily for the 4 week treatment period • The normal treatment period is 4 weeks but your doctor may decide on a different treatment period YOUR PLAQUE PSORIASIS TREATMENT 1. Remove the cap and shake the can for a few seconds before use. Wash and dry hands before application. 2. Apply the foam by holding the can at least 3 cm (just over 1 inch) from the skin and spray directly onto each affected area. Spray the foam by holding the can in any direction except horizontally (on its side). 3. Gently rub the foam spray into each affected skin area. NOTE: Hands should be washed after using Enstilar ® (unless Enstilar ® is used to treat the hands) to avoid accidentally spreading to other parts of the body. • Always follow the guidance of your prescribing doctor • Do not use more than 15 grams per day • One 60 g can should last for at least 4 days • If you use other calcipotriol containing medicines, the total amount of calcipotriol medicines, including Enstilar ® , must not exceed 15 grams per day • Caution: Extremely flammable aerosol. Protect from sunlight and do not store above 30°C. The can should be discarded 6 months after first opening • You must carefully read all of the Patient Information Leaflet (PIL) that is provided with your medicine WANT FURTHER SUPPORT FOR YOUR PSORIASIS? PSORIASIS? QualityCare™ QualityCare™ is a free psoriasis support programme designed for people living with psoriasis. Visit the website for information, tips and tools to help you manage your condition, as well as personal stories from other people living with psoriasis. www.qcbyleo.com www.qcbyleo.com For illustrative purposes only. Individual results may differ. SHAKE SPRAY RUB 3cm

Enstilar patient information leaflet · 2019-11-11 · This leaflet does not replace the Patient Information Leaflet (PIL) provided with your medicine which you must read carefully

Download PDF Report

Upload
others
View
1
Download
0

Embed Size (px)

Citation preview

Page 1: Enstilar patient information leaflet · 2019-11-11 · This leaflet does not replace the Patient Information Leaflet (PIL) provided with your medicine which you must read carefully

Enstilar® foam spray is designed to be sprayed onto your skin. Simply apply where your doctor has indicated, following these simple steps:

Close-up images of patients with psoriasis before Close-up images of patients with psoriasis before treatment and 4 weeks after treatmenttreatment and 4 weeks after treatment

HIP

FORE

ARM

BASELINE WEEK 4

This leaflet is intended forpatients prescribed Enstilar®

(calcipotriol/betamethasonedipropionate) cutaneous foam.

This leaflet does not replacethe Patient Information

Leaflet (PIL) provided withyour medicine which you

must read carefully.

Enstilar® contains calcipotriol and betamethasone dipropionate (50 micrograms/g + 0.5 mg/g) in a foam spray formulation.

• Enstilar® is a foam spray plaquepsoriasis treatment for adult patientsthat comes in a can

• Spray onto the affected area, as directedby your prescriber, once-daily for the 4week treatment period

• The normal treatment period is 4weeks but your doctor may decide on adifferent treatment period

YOUR PLAQUEPSORIASISTREATMENT

1. Remove the cap and shake the can fora few seconds before use. Wash anddry hands before application.

2. Apply the foam by holding the canat least 3 cm (just over 1 inch) fromthe skin and spray directly onto eachaffected area. Spray the foam byholding the can in any direction excepthorizontally (on its side).

3. Gently rub the foam spray into eachaffected skin area.

NOTE: Hands should be washedafter using Enstilar® (unless Enstilar®

is used to treat the hands) to avoidaccidentally spreading to other parts ofthe body.

• Always follow the guidance of your prescribingdoctor

• Do not use more than 15 grams per day

• One 60 g can should last for at least 4 days

• If you use other calcipotriol containing medicines,the total amount of calcipotriol medicines, includingEnstilar®, must not exceed 15 grams per day

• Caution: Extremely flammable aerosol. Protectfrom sunlight and do not store above 30°C. The canshould be discarded 6 months after first opening

• You must carefully read all of the Patient InformationLeaflet (PIL) that is provided with your medicine

WANT FURTHER SUPPORT FOR YOUR PSORIASIS?PSORIASIS?QualityCare™QualityCare™ is a free psoriasis support programme designed for people living with psoriasis. Visit the website for information, tips and tools to help you manage your condition, as well as personal stories from other people living with psoriasis.

www.qcbyleo.com www.qcbyleo.com

For illustrative purposes only. Individual results may differ.

SHAKE SPRAY RUB

3cm

Tearoff Pad.indd 1 03/04/2019 17:001

Page 2: Enstilar patient information leaflet · 2019-11-11 · This leaflet does not replace the Patient Information Leaflet (PIL) provided with your medicine which you must read carefully

UK MAT-07593 V2

Date of Preparation: February 2019

Created by

REPORTING OF SIDE EFFECTSIf you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet.

UK: You can also report side effects directly via Yellow Card Scheme at www.mhra.gov.uk/yellowcard

Ireland: You can also report side effects directly via HPRA Pharmacovigilance, Earlsfort Terrace, IRL – Dublin 2 Tel: +353 1 6764971 Fax: +353 1 6762517 Website: www.hpra.ie Email: [email protected]

By reporting side effects you can help provide more information on the safety of this medicine.

Tearoff Pad.indd 2 03/04/2019 17:002